Direxion Daily S&P Biotech Bull 3X Shares (LABU) seeks to deliver 300% of the daily performance of the S&P Biotechnology Select Industry Index, which measures the performance of biotechnology companies within the S&P Total Market Index. This leveraged ETF provides amplified exposure to biotech stocks developing drugs, therapies, and medical technologies.
How It Works
LABU uses derivatives including swaps and futures contracts to achieve triple the daily return of its benchmark index. The fund rebalances daily to maintain its 3x leverage target, meaning positions are reset each trading day regardless of market direction. As a passively managed ETF, it mechanically tracks the underlying biotech index without stock selection. The strategy requires constant portfolio adjustments to maintain leverage ratios as biotech stock prices fluctuate throughout each trading session.
Key Features
- Provides 3x daily exposure to biotech sector, amplifying both gains and losses compared to unleveraged biotech ETFs
- Daily rebalancing ensures consistent leverage ratio but creates compounding effects unsuitable for multi-day holding periods
- Focuses specifically on S&P biotechnology companies, offering concentrated exposure to drug development and medical innovation themes
Risks
- Daily reset causes severe compounding decay—if biotech stocks drop 10% then rise 10%, LABU does not return to break-even due to leverage mathematics
- Biotech sector volatility amplified 3x can result in 30-60% daily swings during clinical trial announcements or FDA approval decisions
- Extended holding periods virtually guarantee losses even if underlying biotech sector rises, as daily rebalancing erodes returns over time
Who Should Own This
Suitable only for sophisticated day traders with very high risk tolerance and intraday time horizons measured in hours, not days. Requires active monitoring and should represent less than 5% of total portfolio. Not appropriate for buy-and-hold investors or those seeking biotech sector exposure beyond single trading sessions.